Evidence map›Paper›PMID 33726569›Full record

ArticleJournal of the renin-angiotensin-aldosterone system : JRAAS

PM2.5 inducing myocardial fibrosis mediated by Ang II/ERK1/2/TGF-β

Xiwen Zang, Jun Zhao, Chengzhi Lu

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the renin-angiotensin-aldosterone system : JRAAS. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Xiwen ZangTianjin Medical University, Teda International Cardiovascular Hospital, Tianjin, China.
Jun ZhaoTianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease(Key Lab-TIC), Tianjin Institute of Cardiology (TIC), Department of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.ORCID https://orcid.org/0000-0002-8732-9137
Chengzhi LuFirst Center Clinic College of Tianjin Medical University, Tianjin First Center Hospital, Tianjin, China.
Second Hospital of Tianjin Medical University · CNTEDA International Cardiovascular Hospital · CNTianjin First Center Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectsTo discuss the influence of PM2.5 on myocardial fibrosis and related mechanism.

methodsPM2.5 particles were prepared into different concentrations of solution to drip into the mice's trachea twice each week. The mice were divided into five groups, Blank control group (C group), NS control group (J group), high dose group (G group, 10 mg/kg), medium dose group (Z group, 5 mg/kg), and 1ow dose group (D group, 2.5 mg/kg). After 6 weeks, the myocardial fibrosis was observed by HE and Masson staining. The expression of Ang II, ERK1/2, and TGF-β

resultsThe higher dose PM2.5 was administrated, the worse the myocardial fibrosis was in PM2.5 groups. The expression of Ang II, ERK1/2, and TGF-β

conclusion1. PM2.5 induced the cardiac fibrosis. 2. PM2.5 dripped into trachea in mice model activated the expression of Ang II, ERK1/2, and TGF-β

Indexed as

MAP Kinase Signaling SystemAngiotensin IIAnimalsDisease Models, AnimalFibrosisGene Expression RegulationHeart VentriclesMaleMiceMyocardiumParticulate MatterRatsRats, Sprague-DawleyRNA, MessengerTransforming Growth Factor beta1Angiotensin IIParticulate MatterRNA, MessengerTransforming Growth Factor beta1Cardiac fibrosisPM2.5pollutionRAS

Identifiers

PMID33726569
PMCPMC7983242
OpenAlexW3136286789

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.